News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,421 Results
Type
Article (85265)
Company Profile (622)
Press Release (738534)
Section
Business (231859)
Career Advice (4090)
Deals (39621)
Drug Delivery (106)
Drug Development (90430)
Employer Resources (192)
FDA (17887)
Job Trends (17246)
News (394623)
Policy (39583)
Tag
Academia (2973)
Africa (1263)
Alliances (56336)
Alzheimer's disease (1247)
Approvals (17796)
Arizona (210)
Artificial intelligence (86)
Asia (49002)
Australia (8616)
Bankruptcy (392)
Best Places to Work (12253)
Biotechnology (438)
C2C Services and Suppliers (95111)
California (2009)
Canada (939)
Cancer (538)
Career advice (3497)
Cell therapy (142)
China (157)
Clinical research (70432)
Collaboration (152)
Colorado (82)
Compensation (82)
Connecticut (83)
COVID-19 (2754)
Cystic fibrosis (77)
Data (313)
Diabetes (91)
Diagnostics (6500)
Drug pricing (82)
Earnings (93522)
Employer resources (162)
Europe (112018)
Events (124992)
Executive appointments (159)
FDA (18115)
Florida (272)
Funding (154)
Gene therapy (108)
GLP-1 (619)
Government (5007)
Healthcare (20650)
Hotbed/Location (534575)
Illinois (321)
Indiana (161)
Infectious disease (2785)
Inflammatory bowel disease (102)
Interviews (805)
IPO (17488)
Job creations (5172)
Job search strategy (2849)
Kansas (100)
Layoffs (467)
Legal (10012)
Lung cancer (125)
Manufacturing (101)
Maryland (430)
Massachusetts (1716)
Medical device (14264)
Medtech (14269)
Mergers & acquisitions (21959)
Metabolic disorders (296)
Michigan (137)
Minnesota (236)
Neuroscience (1412)
New Jersey (613)
New York (615)
NextGen Class of 2024 (7622)
Non-profit (5053)
North Carolina (700)
Northern California (841)
Obesity (177)
Ohio (110)
Opinion (234)
Patents (75)
Pennsylvania (591)
People (63720)
Pharmaceutical (119)
Phase I (21625)
Phase II (30577)
Phase III (23105)
Pipeline (111)
Podcasts (76)
Postmarket research (3532)
Preclinical (9768)
Press Release (72)
Rare diseases (141)
Real estate (7362)
Recruiting (72)
Regulatory (25598)
Research institute (2633)
Resumes & cover letters (645)
South America (1641)
Southern California (774)
Startups (4272)
Texas (264)
United States (9330)
Vaccines (567)
Washington State (281)
Weight loss (169)
Date
Today (129)
Last 7 days (711)
Last 30 days (2512)
Last 365 days (40065)
2024 (28083)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39126)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 824,421 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
New Long-Term Zeposia (ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in Relapsing Forms of Multiple Sclerosis
September 18, 2024
·
18 min read
Press Releases
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)
September 18, 2024
·
19 min read
Press Releases
Biosyngen’s first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress
September 18, 2024
·
4 min read
Press Releases
Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis
September 18, 2024
·
13 min read
Podcast
Sickle Cell Gene Therapies Reach Patients, Moderna Cuts, Obesity Pill Race and ESMO 2024
Infusions of Vertex and CRISPR Therapeutics’ Casgevy and bluebird bio’s Lyfgenia have begun; Moderna targets 10 approvals through 2027; more oral obesity drug data; the latest from ESMO and more.
September 18, 2024
·
1 min read
·
Heather McKenzie
Press Releases
New Alzheon Peer-Reviewed Scientific Publication Describes Study Design and Baseline Characteristics from APOLLOE4 Phase 3 Trial of Oral ALZ-801/Valiltramiprosate in APOE4/4 Homozygous Individuals with Early Alzheimer’s Disease
September 18, 2024
·
10 min read
Press Releases
IDEAYA Biosciences Appoints Douglas B. Snyder as Senior Vice President, General Counsel
September 18, 2024
·
3 min read
Press Releases
Oxford Brain Diagnostics and Memory Treatment Centers (Bonita Springs and Jacksonville, Florida), establish a research collaboration to explore Alzheimer’s disease in subjects who are cognitively impaired and receiving anti-amyloid treatment.
September 18, 2024
·
3 min read
Press Releases
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
September 18, 2024
·
5 min read
Press Releases
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference
September 18, 2024
·
7 min read
1 of 82,443
Next
